NorthStar Medical Technologies, a global innovator in the production and distribution of radioisotopes used for medical imaging, announces the appointment of Stephen Merrick as President and Chief Executive Officer. Mr Merrick has been with NorthStar since March 2016, initially in the role of Chief Operating Officer and later as President and Chief Operating Officer.
Mr Merrick replaces outgoing Chairman and Chief Executive Officer George Messina, who was named Chairman Emeritus. Mr Messina was simultaneously appointed President and Chief Executive Officer of NorthStar Nuclear Therapies LLC (“NNT”), a wholly-owned subsidiary of NorthStar focused on developing medical isotopes for therapeutic applications. Diane Hendricks, Chairperson of Hendricks Holding Company, Inc. has assumed the Chairperson role for both Companies’ Board of Managers.
“As founder, George has been the driving force from NorthStar’s inception through FDA approval of the RadioGenix System to the initial commercial sale of domestically produced Mo-99. We thank George for his successful leadership in NorthStar’s effort to become the first US-based producer of Mo-99,” said Diane Hendricks, Chairperson of the NorthStar Board of Managers.
“NorthStar is at a transformative point in its evolution from a development stage company to being the first domestic supplier of Mo-99, and we are excited that Steve has agreed to become NorthStar’s President and CEO,” continued Ms Hendricks. “This Company is strongly positioned for rapid growth in the US market and there are attractive opportunities for NorthStar to grow outside the United States as well. Steve’s broad executive experience in the pharmaceutical industry at Bristol-Myers Squibb, Mallinckrodt and Baxter Healthcare, as well as his expertise in product development and driving domestic and global market demand are invaluable to NorthStar’s future success. The Board of Managers believes that this organisational realignment allows NorthStar to capitalise on both George and Steve’s strengths.”
Prior to joining NorthStar, Mr Merrick served as Vice President, International Marketing for Baxter International’s Hospital Products business. Previously, he was Senior Vice President and President - International Commercial Operations for Mallinckrodt Pharmaceuticals and worked in management at Bristol-Myers Squibb for 17 years, holding a series of increasingly responsible positions around the world. Mr Merrick began his career with Eli Lilly and Company.
